CARsgen announced that its autologous CAR T-cell product candidate, CT011, received Investigational New Drug (IND) clearance from the NMPA in China.
Related Keywords
China , Huadong , Guangdong , Raffaele Baffa , , Huadong Medicine ,
comparemela.com © 2020. All Rights Reserved.